Blog & Actualités

Insights & Actualités Tech

Découvrez nos derniers articles sur le développement web, le design et les technologies digitales qui façonnent l'avenir

Recherche pour : "Arma"
Effacer les filtres

Montana’s plan to become an experimental medical hub just pushed forward

As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once...

The path to artificial superintelligence

The path to artificial superintelligence

Imagine a healthcare system made up of multiple AI agents: one that manages symptom assessment, another scheduling, a third insurance, and a fourth pharmacy. Each is an expert in its domain. But they all have their own distinct knowledge and objectives. Today they can exchange data, but they are...

The Download: an organ transplant breakthrough, and homegrown Chinese chips

The Download: an organ transplant breakthrough, and homegrown Chinese chips

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Supercooled kidneys have been transplanted into pigs in a “landmark achievement”  When it comes to organ donation, time is everything. As soon...

Supercooled kidneys have been transplanted into pigs in a “landmark achievement”

Supercooled kidneys have been transplanted into pigs in a “landmark achievement”

When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave it too long and the organ will become unusable. In most cases, organs will be kept on...

How AI helps scientists design the next generation of medicines

How AI helps scientists design the next generation of medicines

Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered...